Work

Crossover from one aromatase inhibitor (AI) to another in the Exemestane and Letrozole Pharmacogenetics (ELPh) trial.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.3_suppl.158

Authors: Kunal C. Kadakia, Kelley M Kidwell, Nicholas J. Seewald, Claire Frances Snyder, David A. Flockhart, Janet S Carpenter, Julie L. Otte, Daniel F. Hayes, Anna Maria Storniolo, Vered Stearns, Norah Lynn Henry

Institutions: U-M Rogel Cancer Center, University of Michigan, Johns Hopkins University, Indiana University School of Medicine, Indiana University Indianapolis, Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587621657

Cites:

Cited by: 3

Related to: 10